SPOTLIGHT -
FDA Approves Chikungunya Virus Vaccine
Ixchiq was approved through the FDA Accelerated Approval pathway.
Class Action Lawsuit Filed Against CVS Caremark to Recoup DIR Fees
The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.
FDA Approves Jardiance for Patients with Chronic Kidney Disease
Jardiance is currently available to treat patients with type 2 diabetes, end stage renal disease and heart failure. It has a list price of $570.48 for a month supply.
New Illinois Law Promotes PBM Transparency
Illinois Governor JB Pritzker signed into law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.
Out-of-Pocket Costs Impact Medication Access for Some Medicare Beneficiaries with Schizophrenia
Low-income subsidies can eliminate much of the out-of-pocket costs that patients must pay.
Cost Savings Associated with Therapeutic Exchange of Stimulant Medications
Cost savings were not associated with an increase in adverse drug events.